Matches in SemOpenAlex for { <https://semopenalex.org/work/W2401134670> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2401134670 endingPage "7" @default.
- W2401134670 startingPage "456" @default.
- W2401134670 abstract "The isolation of a specific competitive inhibitor of the enzyme 3hydroxy-3-methylglutaryl COA reductase from the fungus Aspergillus terreus opened the way for the development of a new family of cholesterol-lowering agents called statins. These statins ± atorvastatin, fluvastatin, lovastatin, pravastatin and simvastatin ± are all available on the Israeli market. Their mechanism of action is to target hepatocytes and reduce cholesterol production by inhibiting HMG COA reductase, a rate-controlling enzyme that converts HMGCOA to mevalonic acid, which is a precursor of cholesterol synthesis. Reduction of cholesterol synthesis in the hepatocyte upregulates hepatic low density lipoprotein receptors, leading to increased removal of plasma LDL-C, intermediate density lipoprotein and very low density lipoproteins [1,2]. Statins reduce the production of apolipoprotein B and increase hepatic apolipoprotein-B/E receptors [3]. Apart from its hypocholesterolemic action, statins have few other anti-atherogenic properties. Cholesterol-lowering by statins results in significant improvement in endothelial function, and reduces the frequency and intensity of ischemic episodes detected by 48 hour Holter monitoring [4]. The statins induce activation of the nitric oxide synthase gene in human endothelial cells [5], decrease smooth muscle growth in vitro [6], and reduce the proliferation of macrophages induced by oxidized LDL-C and its accumulation in the cells [7]. In addition, they may affect the cells' thrombus formation [8], lower the levels of C-reactive protein in the plasma [9], and eliminate the higher risk of cardiovascular events associated with this inflammatory factor. An elevated LDL-C level is the key risk factor for coronary heart disease. Primary and secondary prevention trials have shown that the use of statins to lower LDL-C levels can substantially reduce coronary events, strokes, and death from coronary heart disease [Table 1]. Clinical studies have demonstrated that statins in addition to reduction of CHD morbidity and mortality increase survival in hypercholesterolemic and normocholesterolemic subjects. The Scandinavian Simvastatin Survival Study (4S) [10] showed that reduction of cholesterol by simvastatin reduced all-cause mortality in CHD patients. In this study 4,444 CHD patients with elevated cholesterol levels of 212±310 mg/dl were treated with simvastatin for 5 years. Results showed that all-cause mortality was reduced by 30%, major coronary events by 34%, and coronary death Editorials" @default.
- W2401134670 created "2016-06-24" @default.
- W2401134670 creator A5041809067 @default.
- W2401134670 creator A5070069785 @default.
- W2401134670 date "2002-06-01" @default.
- W2401134670 modified "2023-10-18" @default.
- W2401134670 title "Statins: an effective anti-atherosclerosis therapy." @default.
- W2401134670 cites W2007030771 @default.
- W2401134670 cites W2082669903 @default.
- W2401134670 cites W2084744450 @default.
- W2401134670 cites W2092067196 @default.
- W2401134670 cites W2129750583 @default.
- W2401134670 cites W2145053304 @default.
- W2401134670 cites W2146134563 @default.
- W2401134670 cites W2155598961 @default.
- W2401134670 cites W2322095705 @default.
- W2401134670 cites W2417262914 @default.
- W2401134670 cites W3146415411 @default.
- W2401134670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12073422" @default.
- W2401134670 hasPublicationYear "2002" @default.
- W2401134670 type Work @default.
- W2401134670 sameAs 2401134670 @default.
- W2401134670 citedByCount "0" @default.
- W2401134670 crossrefType "journal-article" @default.
- W2401134670 hasAuthorship W2401134670A5041809067 @default.
- W2401134670 hasAuthorship W2401134670A5070069785 @default.
- W2401134670 hasConcept C104950815 @default.
- W2401134670 hasConcept C126322002 @default.
- W2401134670 hasConcept C134018914 @default.
- W2401134670 hasConcept C134651460 @default.
- W2401134670 hasConcept C181199279 @default.
- W2401134670 hasConcept C185592680 @default.
- W2401134670 hasConcept C2776329913 @default.
- W2401134670 hasConcept C2776839432 @default.
- W2401134670 hasConcept C2777482532 @default.
- W2401134670 hasConcept C2778163477 @default.
- W2401134670 hasConcept C2778417548 @default.
- W2401134670 hasConcept C2779519902 @default.
- W2401134670 hasConcept C2780072125 @default.
- W2401134670 hasConcept C2780940807 @default.
- W2401134670 hasConcept C43554185 @default.
- W2401134670 hasConcept C55493867 @default.
- W2401134670 hasConcept C62746215 @default.
- W2401134670 hasConcept C71924100 @default.
- W2401134670 hasConcept C98274493 @default.
- W2401134670 hasConceptScore W2401134670C104950815 @default.
- W2401134670 hasConceptScore W2401134670C126322002 @default.
- W2401134670 hasConceptScore W2401134670C134018914 @default.
- W2401134670 hasConceptScore W2401134670C134651460 @default.
- W2401134670 hasConceptScore W2401134670C181199279 @default.
- W2401134670 hasConceptScore W2401134670C185592680 @default.
- W2401134670 hasConceptScore W2401134670C2776329913 @default.
- W2401134670 hasConceptScore W2401134670C2776839432 @default.
- W2401134670 hasConceptScore W2401134670C2777482532 @default.
- W2401134670 hasConceptScore W2401134670C2778163477 @default.
- W2401134670 hasConceptScore W2401134670C2778417548 @default.
- W2401134670 hasConceptScore W2401134670C2779519902 @default.
- W2401134670 hasConceptScore W2401134670C2780072125 @default.
- W2401134670 hasConceptScore W2401134670C2780940807 @default.
- W2401134670 hasConceptScore W2401134670C43554185 @default.
- W2401134670 hasConceptScore W2401134670C55493867 @default.
- W2401134670 hasConceptScore W2401134670C62746215 @default.
- W2401134670 hasConceptScore W2401134670C71924100 @default.
- W2401134670 hasConceptScore W2401134670C98274493 @default.
- W2401134670 hasIssue "6" @default.
- W2401134670 hasLocation W24011346701 @default.
- W2401134670 hasOpenAccess W2401134670 @default.
- W2401134670 hasPrimaryLocation W24011346701 @default.
- W2401134670 hasRelatedWork W158929996 @default.
- W2401134670 hasRelatedWork W1778499707 @default.
- W2401134670 hasRelatedWork W1986858103 @default.
- W2401134670 hasRelatedWork W2011843648 @default.
- W2401134670 hasRelatedWork W2116164479 @default.
- W2401134670 hasRelatedWork W2242789166 @default.
- W2401134670 hasRelatedWork W2308863118 @default.
- W2401134670 hasRelatedWork W2401134670 @default.
- W2401134670 hasRelatedWork W285758932 @default.
- W2401134670 hasRelatedWork W2947959412 @default.
- W2401134670 hasVolume "4" @default.
- W2401134670 isParatext "false" @default.
- W2401134670 isRetracted "false" @default.
- W2401134670 magId "2401134670" @default.
- W2401134670 workType "article" @default.